Trials / Completed
CompletedNCT04937556
Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).
Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of the Lactobacillus Probiotic Strain in the Immune Response in Participants Positive for SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2) Infection.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- ProbiSearch SL · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
An interventional, randomized, double-blind, placebo-controlled study will be conducted to investigate the effect of a probiotic strain on the immune response in participants positive for SARS-CoV-2 infection. The study duration will be 28 days, which includes 4 weeks product administration. Participants will be randomized assigned to one of the two study groups: the control group with placebo consumption and a probiotic consumption group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic: Lactobacillus salivarius + Vit D + Zinc | A mixture of 1\*10E9 colony forming unit (CFU) of Lactobacillus salivarius + Vit D + Zinc citrate in 1 capsule will be daily administrated during 28 days. |
| DIETARY_SUPPLEMENT | Placebo | Placebo in 1 capsule will be daily administrated during 28 days. |
Timeline
- Start date
- 2021-10-25
- Primary completion
- 2022-03-25
- Completion
- 2022-04-30
- First posted
- 2021-06-24
- Last updated
- 2022-05-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04937556. Inclusion in this directory is not an endorsement.